Staidson Biopharmaceuticals has supported a $34m series C round for InflaRx, which is working on treatments for acute and chronic inflammatory conditions.

Institutions including Purdue, Florida and Pittsburgh have ended the academic year with TTOs breaking their own records year-on-year.

Six startups have entered the Launchpad Digital Health accelerator and secured funding supplied from investors including Stanford University and the institution's StartX.

Akili Interactive Labs has raised $11.9m in an extension from Merck Group and Amgen, raising the round's total to $42.4m.

Auckland has launched an initiative aimed at bringing renowned researchers to the country, with the government providing $25m in funding.

Celgene has inked a strategic collaboration agreement with Jounce consisting of $36m in equity, $225m in upfront payment and up to $2.3bn in milestone payments.

Pfizer has leapt to the top of the most active corporate venturing investors in US healthcare deals for the first half of 2016, as Novartis falls out of the top 10.

Johnson & Johnson invested $6m to help radiotherapy equipment developer Reflexion Medical close out its Pfizer-backed series B round at $52m.